Current Opinion in Pharmacology

Editorial board
pp. i-i(1)

The demise of old certitudes and the birth of novel opportunities in neuropsychopharmacology
pp. 1-3(3)
Author: Coyle J.T.

AMPA receptor modulators as cognitive enhancers
pp. 4-11(8)
Author: Lynch G.

The kynurenine pathway of tryptophan degradation as a drug target
pp. 12-17(6)
Author: Schwarcz R.

Metabotropic glutamate 2/3 receptors as drug targets
pp. 18-22(5)
Author: Marek G.J.

Glutamate systems in cocaine addiction
pp. 23-29(7)
Author: Kalivas P.W.

Neurotransmitter transporters: why dance with so many partners?
pp. 30-35(6)
Authors: Gonzalez M.I.; Robinson M.B.

Effects of nicotinic stimulation on cognitive performance
pp. 36-46(11)
Authors: Newhouse P.A.; Potter A.; Singh A.

Cotransmission
pp. 47-52(6)
Author: Burnstock G.

What's atypical about atypical antipsychotic drugs?
pp. 53-57(5)
Author: Meltzer H.Y.

Neurotrophic effects of antidepressant drugs
pp. 58-64(7)
Author: Castren E.

Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development
pp. 65-71(7)
Authors: Stanwood G.D.; Levitt P.

Pharmacogenetics and psychopharmacology
pp. 72-78(7)
Authors: Bondy B.; Zill P.

Mutant genes responsible for Parkinson's disease
pp. 79-84(6)
Authors: Le W.; Appel S.H.

Mechanisms of cell death in polyglutamine expansion diseases
pp. 85-90(6)
Authors: Lipinski M.M.; Yuan J.

Recent advances in the pharmacology of neurological gene therapy
pp. 91-97(7)
Authors: Lowenstein P.R.; Castro M.G.

Stem cells as a potential treatment of neurological disorders
pp. 98-104(7)
Authors: Tai Y.-T.; Svendsen C.N.

Molecular mechanisms in the control of gastrointestinal function - Editorial overview
pp. 105-105(1)
Authors: Grundy D.; Winchester W.